Medicover AB
STO:MCOV B
Relative Value
The Relative Value of one
MCOV B
stock under the Base Case scenario is
291.94
SEK.
Compared to the current market price of 217.5 SEK,
Medicover AB
is
Undervalued by 25%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
MCOV B Competitors Multiples
Medicover AB Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
|
Medicover AB
STO:MCOV B
|
32.8B SEK | 1.3 | 40 | 11.3 | 27 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
97.3B USD | 0.2 | 55.1 | 14 | 14 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
65.2B EUR | 0.3 | 12.1 | 7.8 | 9.9 | |
| US |
|
Cigna Corp
NYSE:CI
|
74.6B USD | 0.3 | 12.1 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
29.3B EUR | 1.3 | 25.5 | 11 | 16.8 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
24.2B EUR | 1.2 | 33.6 | 10.6 | 22.5 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23.3B USD | 1.7 | 26.5 | 12.7 | 18.4 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.2B USD | 2 | 22.5 | 12.4 | 16.8 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.9B EUR | 0.6 | 16.4 | 6.5 | 13.8 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
12.9B USD | 14.3 | -32.4 | -34.2 | -31.1 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 0.8 | 13.9 | 7.3 | 9.9 |